Today: 8 June 2026
Browse Category

NYSE:OSCR 3 October 2025 - 4 June 2026

Oscar Health gains after Wells Fargo upgrade

Oscar Health gains after Wells Fargo upgrade

Oscar Health soared 15.5% to $23.68 after Wells Fargo upgraded the stock, citing improved 2026 health-exchange trends despite warning that visibility beyond this year remains low; the move outpaced rivals as traders bet on near-term stability, even as risks from expiring tax credits and policy changes linger.
4 June 2026
·
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health shares rose 3.3% to $12.66 in premarket trading after forecasting 2026 revenue of $18.7–$19.0 billion and operating earnings of $250–$450 million. The company posted a wider Q4 net loss of $353 million and a medical loss ratio of 95.4%. A U.S. House panel subpoenaed Oscar and other insurers over ACA subsidy practices. Oscar also disclosed a new $475 million revolving credit facility.
10 February 2026
·
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health shares traded near $16.63 on December 15, 2025, as the ACA open enrollment deadline coincided with new analyst coverage and policy debate in Washington. Congress is weighing the fate of enhanced ACA premium tax credits set to expire at the end of 2025. KFF projects average subsidized premiums could more than double in 2026 if subsidies lapse. Oscar’s business is heavily exposed to these ACA marketplace shifts.
15 December 2025
·
Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health shares traded near $15.80 on Thursday after closing at $15.59, down 8% despite broader market gains. Stephens & Co. initiated coverage with an “Equal-Weight” rating and a $17 price target. Analyst targets now range from $11 to $25, with volatility metrics remaining elevated. The stock’s 52-week range is $11.20 to $23.80, and market cap stands at about $4.1 billion.
11 December 2025
·
Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health shares jumped 8–9% to about $18.20 by mid-afternoon Wednesday, November 26, 2025, with volume topping 10 million shares. The surge followed a Piper Sandler upgrade to “Overweight” and a new $25 price target, citing Oscar’s margin strategy and earnings potential even if ACA subsidies lapse. Earlier in November, major banks had maintained bearish ratings and lower targets.
26 November 2025
··
Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health shares rose as much as 20% in premarket trading Monday after reports that the White House may propose a two-year extension of enhanced ACA subsidies, with new eligibility limits. The stock traded at $15.47, up about 15% as of 7:56 a.m. ET, according to RTTNews. Oscar recently reported Q3 revenue up 23% year over year to $2.93 billion and membership above 2 million.
24 November 2025
···
Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health announced new individual-market plans for Miami-Dade and four nearby South Florida counties, effective January 1, 2026, with enrollment via HealthCare.gov. The company also introduced HelloMeno, a menopause-focused plan with Elektra Health, available in multiple states for 2026. Managed-care stocks fell after Trump criticized ACA subsidies, pressuring marketplace insurers.
10 November 2025
··
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health reported Q3 revenue of $2.99 billion, up 23% year-over-year but below analyst estimates. The company posted a net loss of $137.5 million, or –$0.53 per share, beating EPS expectations. Medical loss ratio rose to 88.5%. Oscar exchanged $187.5 million of 2031 notes for about 23.3 million shares and reaffirmed its 2025 outlook.
6 November 2025
··
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health shares jumped 11% to $21.50 on Oct. 3, 2025, and traded near $21.76 on Oct. 14, up roughly 40% year-to-date. The company announced a $410 million convertible debt offering to fund AI initiatives and launched a new employer health plan with Hy-Vee. Q2 revenue rose to about $2.9 billion, but net losses widened to $228 million. Analysts remain bearish, with an average price target near $12.
17 October 2025
··
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets on ACA Hopes and Tech-Driven Growth – Can the Insurtech Finally Turn a Profit?

Oscar Health closed at $22.30 on Oct. 6, 2025, with a market cap near $5.6 billion after surging 42% year-to-date. Q2 revenue rose 29% to $2.86 billion, but the company posted a $228 million net loss as its medical loss ratio jumped to 91.1%. Membership topped 2 million. Wall Street consensus remains “Strong Sell,” with an average 12-month price target of $12.
6 October 2025
·
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health shares traded near $19.81 midday Oct. 3, up about 2.8%, with a market cap around $4.9 billion. The company reported Q2 revenue of $2.86 billion and a $228 million net loss, serving about 2 million members, mostly in ACA exchanges. On Sep. 11, Oscar announced a $350 million convertible note offering to fund growth and retire its credit line. Analyst ratings remain cautious, with recent downgrades citing ACA risk.
3 October 2025
·

Stock Market Today

  • Bond Market Warning Signal Overlooked by Many Investors
    June 8, 2026, 5:27 PM EDT. Martin Pelletier, CFA, senior portfolio manager at TriVest Wealth, highlights a critical warning signal in the bond market often missed by investors. TriVest Wealth, part of Wellington-Altus Private Counsel Inc., specializes in risk-managed portfolios and advanced wealth planning. Pelletier's insights emphasize the importance of recognizing early indicators that could impact bond investments amid market volatility. His analysis warns that overlooking these signals may lead to unanticipated risks, urging investors to stay vigilant and consider comprehensive strategies to safeguard portfolios.

Latest articles

IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

8 June 2026
IREN surged 9% to $59.19 as investors returned to crypto and AI infrastructure stocks after last week’s selloff, driven by a $3.65 billion investment-grade GPU financing to support its Microsoft AI cloud contract and news of a planned 800MW data-center in Australia, but future gains hinge on execution, contract delivery, and bitcoin price stability.
SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

8 June 2026
SmartKem shares soared as much as 150% to $1.135 before settling at $0.84 after SRx Health Solutions disclosed a 4.99% stake and purchase of convertible preferred securities, injecting new investor interest as SmartKem faces a Sept. 1 Nasdaq delisting risk for trading below $1 and warns of “substantial doubt” about its ability to continue as a going concern.
Texxon Trading Halted Six Times as NPT Jumps 284% in New York

Texxon Trading Halted Six Times as NPT Jumps 284% in New York

8 June 2026
Texxon shares soared 283.7% to $4.95, briefly topping $12 before closing just below their $5 IPO price, with trading paused six times for volatility and volume over six times shares outstanding; the company warned that similar IPOs had seen sharp, non-fundamental price swings, highlighting ongoing risk for investors.
Social Security Payments Land This Week—June 10 Recipients

Social Security Payments Land This Week—June 10 Recipients

8 June 2026
Social Security’s retirement trust fund could force a 24% benefit cut by 2032, slashing average monthly payments by about $500 for retirees, according to the Committee for a Responsible Federal Budget, as the official trustees project full benefits only until 2033 and continuing income covering just 77% thereafter.
IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

8 June 2026
IonQ surged 10.5% to $62.77, outpacing quantum peers after Quantinuum’s $1.68 billion Nasdaq IPO gave investors a new benchmark for trapped-ion quantum stocks; IonQ’s rally follows its May guidance raise and soaring revenue, but losses and a long commercialization timeline remain key risks.
Go toTop